|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Influence of coagulation factor, vitamin K epoxide reductasecomplex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements显示文摘 | AQUILANTE CL LANGAEE TY LOPEZ LM | 2006 | Clin PharmacolTher2006，78，4： | 1 |
| 2 | An ampD gene in pseudomonas aeruginosa encodes a negative regulator of AmpC beta-lactamase expression显示文摘 | Langaee TY Dargis M Huletsky A | 1998 | Antimicrob Agents Chemother1998，42，12： | 1 |
| 3 | Influence of coagulation factor,vitamin K epoxide reductase complex subunit 1,and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements显示文摘 | Aquilante CL Langaee TY Lopez LM | 2006 | Clin Pharmacol Ther2006，79，4： | 1 |
| 4 | Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements 显示文摘 | Aqui lante CL Langaee TY Lopez LM | 2006 | Clin Pharmacol Ther2006，79，： | 1 |
| 5 | Association of CYP3A5 polymorphisms with hypertension and antihypertensive response to verapamil 显示文摘 | Langaee TY Gong Y Yarandi HN | 2007 | Clin Pharmacol Ther2007，81，3： | 1 |
| 6 | Inactivation of the ampD gene in Pseudomonas aeruginosa leads to moderate-basal-level and hyperinducible AmpCβ-lactamases expression显示文摘 | Langaee TY Gagnon L Huletsky A | 2000 | Antimicrob Agents Chemother2000，44，： | 1 |
| 7 | Genetic and clinical predictors of warfarin dose requirements in African Americans显示文摘 | Cavallari LH Langaee TY Momary KM | 2010 | Clin Pharmacol Ther2010，87，4： | 1 |
| 8 | Tile effect of tdmethoprim on CYP2C8 mediated rosiglitazone metabolism in human liver microsomes and healthy subjects显示文摘 | Hruska MW Amico JA Langaee TY | 2005 | Br J Clin Pharmacol2005，59，1： | 1 |
| 9 | Association of CYP3A5 polymorphisms with hypertension and antihypertensive response to ver- apamil显示文摘 | Langaee TY Gong Y Yarandi HN | 2007 | Clin Pharmacol Ther2007，81，3： | 1 |
| 10 | CXCL5 gene polymorphisms are related to systemic concentrations and leuko- cyte production of epithelial neutrophil-activating peptide (ENA-78)显示文摘 | ZINEH I AAUILANTE CL LANGAEE TY | 2006 | Cytokine2006，33，5： | 1 |
| 11 | Influence of coagulation factor,vitamin K epoxide reductase complex subunit 1, and cytochmme P450 2C9 gene polymorphisms on warfarin dose requirements 显示文摘 | Aquilante CL Langaee TY Lopez LM | 2006 | Clin Pharmacol Ther2006，79，4： | 1 |
| 12 | A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose显示文摘 | Cooper GM Johnson JA Langaee TY | 2008 | Blood2008，112，4： | 1 |
| 13 | Inactivation of the ampD gene in Pseudomonas aeruginosa leads to moderate-basal-level and hyperinducible AmpCβ-lactamases expression显示文摘 | Langaee TY Gagnon L Huletsky A | 2000 | Antimicrob Agents Chemother2000，44，： | 1 |
| 14 | Influence of coagulation factor,vitamin K epoxide reductase complex subunit 1,and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements显示文摘 | Aquilante CL Langaee TY Lopez LM | 2006 | Clin Pharmacol Ther2006，79，4： | 1 |
| 15 | Association of apolipoprotein E genotype with duration of time to achieve a stable warfarin dose in African-American patients显示文摘 | Cavallari LH Butler C Langaee TY | 2011 | Pharmacotherapy2011，31，： | 1 |
| 16 | An ampD gene in Pseudomonas aeruginosa encodes a negative regulator of AmpC-β-lactamase expression 显示文摘 | Langaee TY Dargis M Huletsky A | 1998 | Antimicrob Agents Chemother1998，42，12： | 1 |
| 17 | Influence of coagulation factor,vitamin K epoxide reductase complex subunit 1,and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements显示文摘 | Aquilante CL Langaee TY Lopez LM Yarandi HN Tromberg JS MOhuczy D | 2006 | Clin Pharmacol Ther2006，79，： | 1 |
| 18 | Association of CYP3A5 polymorphisms with hypertension and antihy- pertensive response to veraparnil显示文摘 | Langaee TY Gong Y Yarandi HN | 2007 | Clin Pharmacol T- her2007，81，4： | 1 |
| 19 | Influence of coagulation factor,vitamin K epoxide reductase complex subunit 1,and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements显示文摘 | Langaee TY Lopez LM | 2006 | Clin Pharmacol Ther2006，79，4： | 1 |
| 20 | Ge- netic and clinical predictors of warfarin dose require- ments in African Americans 显示文摘 | Cavallari LH Langaee TY Momary KM | 2010 | Clin Pharmacol T- her2010，87，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员